Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001144204-16-125427
Filing Date
2016-09-27
Accepted
2016-09-27 08:30:30
Documents
2
Period of Report
2016-09-27

Document Format Files

Seq Description Document Type Size
1 FORM 6-K v449425_6k.htm 6-K 120314
2 GRAPHIC image_001.jpg GRAPHIC 3938
  Complete submission text file 0001144204-16-125427.txt   126851
Mailing Address 5 HACHAROSHET ST. RAANANA L3 4365603
Business Address XTL BIOPHARMACEUTICALS LTD C/O ALSTON & BIRD LLP, 90 PARK AVENUE NEW YORK NY 10016 972 9 955 7080
XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

EIN.: 000000000
Type: 6-K | Act: 34 | File No.: 001-36000 | Film No.: 161903380
SIC: 2834 Pharmaceutical Preparations